Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Handling Temperature-Sensitive Injectable Formulations – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Handling Temperature-Sensitive Injectable Formulations – V 2.0

Standard Operating Procedure for Handling Temperature-Sensitive Injectable Formulations


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/129/2025
Supersedes SOP/SIM/129/2022
Page No. Page 1 of 15
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

To define a standard procedure for the safe handling, storage, transportation, and processing of temperature-sensitive injectable formulations to ensure product integrity and regulatory compliance.

2. Scope

This SOP is applicable to all temperature-sensitive sterile injectable formulations handled within the production and warehousing areas, including cold-chain materials requiring 2°C

to 8°C, frozen items, and controlled room temperature (CRT) materials.

3. Responsibilities

  • Warehouse Personnel: Store materials at designated temperature zones and maintain temperature logs.
  • Production Operators: Handle and use materials as per the prescribed temperature limits.
  • QA Personnel: Monitor compliance and review deviations and excursions.
  • Engineering: Ensure temperature-controlled equipment functions correctly.
See also  Sterile Injectable Manufacturing: SOP for Monitoring Temperature during Sterile Filling - V 2.0

4. Accountability

The Head of Production and QA is accountable for ensuring compliance with this SOP, training of staff, and resolution of deviations related to temperature-sensitive materials.

5. Procedure

5.1 Receipt of Temperature-Sensitive Materials

  1. Receive temperature-sensitive materials with temperature indicators or data loggers.
  2. Verify during receipt that the transport temperature was maintained.
  3. If excursion is suspected, quarantine the batch and inform QA for evaluation.

5.2 Storage Requirements

  1. Store materials in temperature-mapped storage areas:
    • Cold Room (2–8°C)
    • Freezer (-20°C)
    • CRT (15–25°C)
  2. Label each container with “Temperature-Sensitive” and the required storage condition.
  3. Use calibrated digital temperature sensors with alarm systems.

5.3 Material Transfer

  1. Use validated cold boxes or portable refrigerators during material transfer to manufacturing areas.
  2. Monitor transfer duration and environmental conditions using portable data loggers.

5.4 During Manufacturing

  1. Ensure manufacturing room conditions are within acceptable temperature limits.
  2. Use temperature-controlled equipment such as jacketed tanks and insulated transfer lines if required.
  3. Record batch start and end time for temperature-sensitive steps.
See also  Sterile Injectable Manufacturing: SOP for Lyophilization Process in Injectable Manufacturing - V 2.0

5.5 Monitoring

  1. Monitor all temperature-controlled areas continuously using automated systems.
  2. Daily checks must be documented in the Temperature Monitoring Log (Annexure-1).

5.6 Handling Temperature Excursions

  1. If any excursion is noted:
    • Segregate affected materials immediately.
    • Document in the Temperature Excursion Log (Annexure-2).
    • Conduct impact assessment with QA.

5.7 Documentation

  1. All storage equipment calibration records must be maintained.
  2. Include temperature verification in the Batch Manufacturing Record (Annexure-3).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • CRT: Controlled Room Temperature
  • BMR: Batch Manufacturing Record

7. Documents

  1. Temperature Monitoring Log – Annexure-1
  2. Temperature Excursion Log – Annexure-2
  3. Batch Manufacturing Record – Annexure-3

8. References

  • WHO Guidelines on Good Storage Practices
  • EU GMP Annex 1
  • ICH Q10 – Pharmaceutical Quality System
See also  Quality Assurance: SOP for Managing Deviations in Quality Assurance Processes - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Temperature Monitoring Log

Date Location Min Temp (°C) Max Temp (°C) Checked By
23/06/2025 Cold Room 2.1 7.8 Rajesh Kumar

Annexure-2: Temperature Excursion Log

Date Location Observed Temp Duration Material ID Action Taken
20/06/2025 CRT Store 29°C 1 hour APX123 Under Evaluation

Annexure-3: BMR Temperature Verification Section

Batch No. Start Temp (°C) End Temp (°C) Operator QA Verified
B1256 7.5 7.3 Sunita Reddy Yes

Revision History

Revision Date Revision No. Details Reason Approved By
10/04/2022 1.0 Initial version New SOP QA Head
24/06/2025 2.0 Updated transfer and documentation protocols Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Biosimilars: SOP for Buffer Exchange Using TFF – V 2.0
Next Post: Gel Manufacturing: SOP for Sampling of Raw Materials for Gel Formulations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version